Biogen faces a crisis after failure of Alzheimer's drug
For the full story, click here. Biogen has been hit hard after the failure of its drug Aduhelm. The Massachusetts-based biotech company had high hopes in the first Alzheimer's trea…
For the full story, click here. Biogen has been hit hard after the failure of its drug Aduhelm. The Massachusetts-based biotech company had high hopes in the first Alzheimer's trea…